Beat the Market the Zacks Way: ADMA Biologics, Carlisle, McCormick Manufacturing in Focus

Zacks04-29

Last week, two of the three major U.S. indexes — the S&P 500 and the tech-heavy Nasdaq Composite — gained 1.8% and 3.1%, respectively, whereas the Dow Jones Industrial Average ended virtually ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2431622668?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/llEIJtlHISQ_iDpj2RC5GA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/debc48c0a0afd8d3a2d2dcb320e026fe","is_english":true,"pubTime":"2024-04-29 20:16","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2431622668","market":"us","top_or_hot":-1,"title":"Beat the Market the Zacks Way: ADMA Biologics, Carlisle, McCormick Manufacturing in Focus","media":"Zacks","content":"<div>\n<p>Last week, two of the three major U.S. indexes — the S&P 500 and the tech-heavy Nasdaq Composite — gained 1.8% and 3.1%, respectively, whereas the Dow Jones Industrial Average ended virtually ...</p>\n\n<a href=\"https://finance.yahoo.com/news/beat-market-zacks-way-adma-121600323.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beat the Market the Zacks Way: ADMA Biologics, Carlisle, McCormick Manufacturing in Focus</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeat the Market the Zacks Way: ADMA Biologics, Carlisle, McCormick Manufacturing in Focus\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-29 20:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/beat-market-zacks-way-adma-121600323.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Last week, two of the three major U.S. indexes — the S&P 500 and the tech-heavy Nasdaq Composite — gained 1.8% and 3.1%, respectively, whereas the Dow Jones Industrial Average ended virtually ...</p>\n\n<a href=\"https://finance.yahoo.com/news/beat-market-zacks-way-adma-121600323.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4527","symbol_name":"明星科技股","start_time":0,"source_url":"https://finance.yahoo.com/news/beat-market-zacks-way-adma-121600323.html","article_id":"2431622668","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/llEIJtlHISQ_iDpj2RC5GA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/debc48c0a0afd8d3a2d2dcb320e026fe"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2431622668","pubTimestamp":1714392960,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Last week, two of the three major U.S. indexes — the S&P 500 and the tech-heavy Nasdaq Composite — gained 1.8% and 3.1%, respectively, whereas the Dow Jones Industrial Average ended virtually unchanged. This clearly shows indecisiveness in the market despite solid corporate earnings.From January through March 2024, the U.S. economy grew at the slowest pace in nearly two years at 1.6% against the Wall Street expectation of 2.4%. The numbers suggest a significant loss of momentum since the beginning of 2024 due to a sharp rise in inflation which led to a cool-off in consumer and government spending.Also, the personal consumption expenditure price index rose 3.4% in the first quarter against 1.8% in the previous quarter. This raised concerns over rising inflation and the timing of the planned rate cuts by the Federal Reserve.On the international front, rising geopolitical tension between Israel and its neighbors, are still a concern for global oil prices and supply chain, which could lead","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4527":"明星科技股","MKC":"味好美","BK4588":"碎股","NVO":"诺和诺德","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","LU0985320562.USD":"NORDEA 1 GLOBAL STARS EQUITY \"BP\" (USD) ACC","CL":"高露洁","BK4503":"景林资产持仓","FDN":"First Trust Dow Jones Internet I","UPRO":"三倍做多标普500ETF","SPY":"标普500ETF","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist","LU0731783394.SGD":"Fidelity Global Dividend A-MINCOME(G)-SGD","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","BHKLY":"中银香港ADR","BK4086":"建筑产品","NOBL":"ProShares S&P 500 Aristocrats ETF","BK4581":"高盛持仓","BK4085":"互动家庭娱乐","BK4504":"桥水持仓","MU":"美光科技","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","SG9999004360.SGD":"Nikko AM Shenton Thrift Fund SGD","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","SG9999013460.SGD":"LionGlobal Singapore Dividend Equity Fund SGD","ADMA":"ADMA Biologics Inc","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","SG9999013478.USD":"利安新加坡股息基金","IVV":"标普500指数ETF","IE0034224299.USD":"PINEBRIDGE ASIA EX JAPAN EQUITY \"A\" (USD) ACC","BK4212":"包装食品与肉类","ECDP":"Eco Depot, Inc.","SSO":"两倍做多标普500ETF","CSL":"卡莱尔伙伴","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","TSCO":"拖拉机供应公司","SDS":"两倍做空标普500ETF",".SPX":"S&P 500 Index","OEX":"标普100","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","BK4157":"电子设备和仪器","ALSN":"艾里逊变速箱控股公司","VOO":"Vanguard标普500ETF","SE":"Sea Ltd","LU1267930813.SGD":"FRANKLIN TEMPLETON SHARIAH GLOBAL EQUITY \"AS\" (SGD) ACC","SH":"标普500反向ETF","BMI":"Badger Meter","OEF":"标普100指数ETF-iShares","SPXU":"三倍做空标普500ETF"},"translate_title":"以咤克斯的方式战胜市场：ADMA Biologics，Carlisle，McCormick Manufacturing聚焦","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ADMA":1,"ALSN":1,"BHKLY":1,"TSCO":1,"SE":1,"NVO":1,"NOBL":1,"MU":1,"ECDP":1,"CSL":1,"BMI":1,"CL":1,"VOO":0.9,"SPY":0.9,"MKC":0.9,"FDN":0.7,"OEX":0.6,"SDS":0.6,"SH":0.6,"SPXU":0.6,"SSO":0.6,"UPRO":0.6,".SPX":0.6,"ESmain":0.6,"IVV":0.6,"OEF":0.6},"content_text":"Last week, two of the three major U.S. indexes — the S&P 500 and the tech-heavy Nasdaq Composite — gained 1.8% and 3.1%, respectively, whereas the Dow Jones Industrial Average ended virtually unchanged. This clearly shows indecisiveness in the market despite solid corporate earnings.\nFrom January through March 2024, the U.S. economy grew at the slowest pace in nearly two years at 1.6% against the Wall Street expectation of 2.4%. The numbers suggest a significant loss of momentum since the beginning of 2024 due to a sharp rise in inflation which led to a cool-off in consumer and government spending.\nAlso, the personal consumption expenditure price index rose 3.4% in the first quarter against 1.8% in the previous quarter. This raised concerns over rising inflation and the timing of the planned rate cuts by the Federal Reserve.\nOn the international front, rising geopolitical tension between Israel and its neighbors, are still a concern for global oil prices and supply chain, which could lead to an increase in inflation worries.\nRegardless of market conditions, we here at Zacks provide investors with unbiased guidance on how to beat the market. \nAs usual, Zacks Research guided investors over the past three months with its time-tested methodologies. Given the prevailing market uncertainty, you may want to look at our feats to prepare better for your next action.\nHere are some of our key achievements:\nADMA Biologics and BOC Hong Kong Surge Following Zacks Rank Upgrade \nShares of ADMA Biologics, Inc. ADMA have gained 18.7% (versus the S&P 500’s 1.7% increase) since it was upgraded to a Zacks Rank #1 (Strong Buy) on February 28.\nAnother stock, BOC Hong Kong (Holdings) Limited BHKLY, which was upgraded to a Zacks Rank #2 (Buy) on February 26, has returned 15.7% (versus the S&P 500’s 1.3% increase) since then.\nZacks Rank, our short-term rating system, has earnings estimate revisions at its core. Empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. \nA hypothetical portfolio of Zacks Rank #1 stocks returned +20.63% in 2023 vs. +24.83% for the S&P 500 index and +15% for the equal-weight S&P 500 index. The portfolio of Zacks Rank #1 stocks is an equal-weight portfolio, while the S&P 500 index is a market-cap-weighted index that has been notably distorted by the concentrated performance of mega-cap stocks in 2023.\nWe are not trying to cherry-pick here. But since this Zacks Model portfolio, consisting of Zacks Rank #1 stocks, is an equal-weight portfolio, the equal-weight S&P 500 index is the appropriate benchmark for comparison. Looked at this way, this portfolio has handily outperformed the index.\nThe Zacks Model Portfolio — consisting of Zacks Rank #1 stocks — has outperformed the S&P index by more than 13 percentage points since 1988 (Through January 1, 2024, the Zacks # 1 Rank stocks generated an annualized return of +24.18% since 1988 vs. +10.88% for the S&P 500 index).You can see the complete list of today’s Zacks Rank #1 stocks here >>>\nCheck ADMA Biologics’ historical EPS and Sales here>>>\nCheck BOC Hong Kong’s historical EPS and Sales here>>>\nImage Source: Zacks Investment Research\nZacks Recommendation Upgrades Carlisle Companies and Allison Transmission Higher  \nShares of Carlisle Companies CSL and Allison Transmission Holdings, Inc.  ALSN have advanced 16% (versus the S&P 500’s 2.5% rise) and 6.6% (versus the S&P 500’s 3.0% rise), respectively, since their Zacks Recommendation was upgraded to Outperform on February 16 and February 15, respectively.\nWhile the Zacks Rank is our short-term rating system that is most effective over the one- to three-month holding horizon, the Zacks Recommendation aims to predict performance over the next 6 to 12 months. However, just like the Zacks Rank, the foundation for the Zacks Recommendation is trends in earnings estimate revisions.\nThe Zacks Recommendation classifies stocks into three groups — Outperform, Neutral and Underperform. While these recommendations are determined quantitatively, our analysts have the flexibility to override them for the 1100+ stocks they closely follow based on their better judgment of factors such as valuation, industry conditions and management effectiveness than the quantitative model.\nTo access our research reports with Zacks Recommendations for the 1100+ stocks we cover, click here>>>\nZacks Focus List Stocks Sea Limited, Micron Technology Shoot Up\nShares of Sea Limited SE, which belongs to the Zacks Focus List, have gained 50% over the past 12 weeks. The stock was added to the Focus List on March 26, 2020. Another Focus-List holding, Micron Technology, Inc. MU, which was added to the portfolio on December 27, 2016, has returned 32.8% over the past 12 weeks. The S&P 500 has advanced 2.81% over this period. \nThe 50-stock Zacks Focus List model portfolio returned +21.72% in 2023 (through November 30) vs. +20.79% for the S&P 500 index and +6.32% for the equal-weight S&P 500 index. In 2022, the portfolio produced -15.2% vs. the S&P 500 index’s -17.96%.\nSince 2004, the Focus List portfolio has produced an annualized return of +11.07% through November 30, 2023. This compares to a +9.49% annualized return for the S&P 500 index in the same time period.\nOn a rolling one-, three- and five-year annualized basis, the Zacks Focus List returned +13.49%, +9.21%, and +14.05% vs. +13.82%, +9.74% and +12.51% for the S&P 500 index, respectively.\nUnlock all of our powerful research, tools and analysis, including the Focus List, Zacks #1 Rank List, Equity Research Reports, Zacks Earnings ESP Filter, Premium Screener and more, as part of Zacks Premium. Gain full access now >>\nZacks ECAP Stocks McCormick & Company and Novo Nordisk Make Significant Gains\nMcCormick & Company, Incorporated MKC, a component of our Earnings Certain Admiral Portfolio (ECAP), has jumped 11.9% over the past 12 weeks. Novo Nordisk A/S NVO has followed McCormick & Company, Incorporated with 11.6% returns.\nThe Zacks Earnings Certain Admiral Portfolio (ECAP), which consists of 30 concentrated, ultra-defensive, long-term Buy and Hold stocks, returned +12.17% in 2023 vs. +26.28% for the S&P 500 index. The portfolio returned -4.7% in 2022 vs. the S&P 500 index’s -17.96%.\nWith little to no turnover and annual rebalance periodicity, the ECAP seeks to minimize capital loss by holding shares of companies whose earnings streams exhibit a proven 20+ year track record of surviving recessionary periods with minimal impact on aggregate earnings growth relative to the overall S&P 500.\nThe ECAP and many other model portfolios are available as part of Zacks Advisor Tools, a cloud-based solution to access Zacks award-winning stock, mutual fund and ETF research. Click here to schedule a demo.\nZacks ECDP Stocks Tractor Supply and Colgate-Palmolive Outperform Peers\nTractor Supply Company TSCO, which is part of our Earnings Certain Dividend Portfolio (ECDP), has returned 17.6% over the past 12 weeks. Another ECDP stock, Colgate-Palmolive Company CL, has climbed 7.6% over the same time frame. Of course, the inclination of investors toward quality dividend stocks to secure an income stream amid heightened market volatility contributed to this performance.\nCheck Tractor Suppply Company’s dividend history here>>>\nCheck Colgate-Palmolive’ dividend history here>>>\nWith an extremely low Beta and a history of minimum earnings variability over the last 20+ years, this 25-stock portfolio helps significantly mitigate risk.\nThe Zacks Earnings Certain Dividend Portfolio (ECDP) returned -0.9% in 2023 vs. +26.28% for the S&P 500 index) and +8.11% for the Dividend Aristocrats ETF (NOBL). The portfolio returned -2.3% in 2022 vs. -17.96% for the S&P 500 index and -8.34% for NOBL.\nClick here to access this portfolio on Zacks Advisor Tools.  \nZacks Top 10 Stocks — Badger Meter Delivers Solid Returns\nBadger Meter, Inc. BMI, from the Zacks Top 10 Stocks for 2024, has jumped 20.2% year to date, which compares to the S&P 500 index’s +6.9% increase.\nThe Top 10 portfolio returned +25.15% in 2023 vs. +26.28% for the S&P 500 index. Since 2012, the Top 10 portfolio has produced a cumulative return of +1060.9% through the end of 2023 vs. +360.1% for the S&P 500 index.\nOn a rolling one-, three- and five-year annualized basis, the Zacks Top 10 portfolio returned +25.15%, +14.13%, and +29.3% vs. +26.28%, +10.23% and +15.61% for the S&P 500 index, respectively.\nSince 2012, the Zacks Top 10 portfolio has returned an annualized return of +22.67% through the end of 2023 vs. +13.56% for the S&P 500 index.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nNovo Nordisk A/S (NVO) : Free Stock Analysis Report\nBadger Meter, Inc. (BMI) : Free Stock Analysis Report\nMicron Technology, Inc. (MU) : Free Stock Analysis Report\nTractor Supply Company (TSCO) : Free Stock Analysis Report\nColgate-Palmolive Company (CL) : Free Stock Analysis Report\nSea Limited Sponsored ADR (SE) : Free Stock Analysis Report\nMcCormick & Company, Incorporated (MKC) : Free Stock Analysis Report\nCarlisle Companies Incorporated (CSL) : Free Stock Analysis Report\nAllison Transmission Holdings, Inc. (ALSN) : Free Stock Analysis Report\nADMA Biologics Inc (ADMA) : Free Stock Analysis Report\nProShares S&P 500 Dividend Aristocrats ETF (NOBL): ETF Research Reports\nBOC Hong Kong Ltd. (BHKLY) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2431622668"}